Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 549

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Crystal Structure of the Tetramerization Domain of the p53 Tumor Suppressor at 1.7 Angstroms

Jeffrey, Philip D., Gorina, Svetlana, Pavletich, Nikola P.·1995·Science
DOI 10.1126/science.7878469
Open this paper in CoChat — free account

Abstract

The p53 protein is a tetrameric transcription factor that plays a central role in the prevention of neoplastic transformation. Oligomerization appears to be essential for the tumor suppressing activity of p53 because oligomerization-deficient p53 mutants cannot suppress the growth of carcinoma cell lines. The crystal structure of the tetramerization domain of p53 (residues 325 to 356) was determined at 1.7 angstrom resolution and refined to a crystallographic R factor of 19.2 percent. The monomer, which consists of a β strand and an α helix, associates with a second monomer across an antiparallel β sheet and an antiparallel helix-helix interface to form a dimer. Two of these dimers associate across a second and distinct parallel helix-helix interface to form the tetramer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.7878469

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 44

  1. BANNER, D.W., STRUCTURE OF THE CO1E1 ROP PROTEIN AT 1.7 A RESOLUTION, JOURNAL OF MOLECULAR BIOLOGY 196: 657 (1987). · DOI · Paper page
  2. BARGONETTI, J, WILD-TYPE BUT NOT MUTANT P53 IMMUNOPURIFIED PROTEINS BIND TO SEQUENCES ADJACENT TO THE SV40 ORIGIN OF REPLICATION, CELL 65: 1083 (1991). · DOI
  3. BARGONETTI, J, A PROTEOLYTIC FRAGMENT FROM THE CENTRAL REGION OF P53 HAS MARKED SEQUENCE-SPECIFIC DNA-BINDING ACTIVITY WHEN GENERATED FROM WILD-TYPE BUT NOT FROM ONCOGENIC MUTANT P53-PROTEIN, GENES & DEVELOPMENT 7: 2565 (1993). · DOI
  4. 10.1126/science.235.4787.458 · DOI
  5. CARSON, M, RIBBONS 2 0, JOURNAL OF APPLIED CRYSTALLOGRAPHY 24: 958 (1991). · DOI
  6. CLORE, G.M., HIGH-RESOLUTION STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTIDIMENSIONAL NMR, SCIENCE 265: 386 (1994). · DOI
  7. 10.1126/science.7878474 · DOI
  8. CONNOLLY, M.L., ANALYTICAL MOLECULAR-SURFACE CALCULATION, JOURNAL OF APPLIED CRYSTALLOGRAPHY 16: 548 (1983). · DOI
  9. DITTMER, D, GAIN OF FUNCTION MUTATIONS IN P53, NATURE GENETICS 4: 42 (1993). · DOI · Paper page
  10. 10.1126/science.2144363 · DOI
  11. 10.1107/S0021889887012299 · DOI · Paper page
  12. FUJINAGA, M, J APPL CRYSTALLOGR 20: 273 (1987). · DOI
  13. FUNK, W.D., A TRANSCRIPTIONALLY ACTIVE DNA-BINDING SITE FOR HUMAN P53 PROTEIN COMPLEXES, MOLECULAR AND CELLULAR BIOLOGY 12: 2866 (1992).
  14. FUREY, W, AM CRYSTALLOGR ASS 2 18: 73 (1990).
  15. GREENBLATT, M.S., MUTATIONS IN THE P53 TUMOR-SUPPRESSOR GENE - CLUES TO CANCER ETIOLOGY AND MOLECULAR PATHOGENESIS, CANCER RESEARCH 54: 4855 (1994).
  16. HALVEY, O, SCIENCE 250: 113 (1990). · DOI
  17. HARTWELL, L, DEFECTS IN A CELL-CYCLE CHECKPOINT MAY BE RESPONSIBLE FOR THE GENOMIC INSTABILITY OF CANCER-CELLS, CELL 71: 543 (1992). · DOI · Paper page
  18. 10.1126/science.8091232 · DOI
  19. 10.1128/jvi.63.2.739-746.1989 · DOI · Paper page
  20. HINDS, P.W., MUTANT P53 DNA CLONES FROM HUMAN COLON CARCINOMAS COOPERATE WITH RAS IN TRANSFORMING PRIMARY RAT-CELLS - A COMPARISON OF THE HOT-SPOT MUTANT PHENOTYPES, CELL GROWTH & DIFFERENTIATION 1: 571 (1990).
  21. HUPP, T.R., REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53, CELL 71: 875 (1992). · DOI · Paper page
  22. 10.1126/science.2047879 · DOI · Paper page
  23. KERN, S.E., ONCOGENIC FORMS OF P53 INHIBIT P53-REGULATED GENE-EXPRESSION, SCIENCE 256: 827 (1992). · DOI
  24. LEE, W, SOLUTION STRUCTURE OF THE TETRAMERIC MINIMUM TRANSFORMING DOMAIN OF P53, NATURE STRUCTURAL BIOLOGY 1: 877 (1994). · DOI
  25. LEVINE, A.J., THE P53 TUMOR SUPPRESSOR GENE, NATURE 351: 453 (1991). · DOI
  26. LIN, J.Y., SEVERAL HYDROPHOBIC AMINO-ACIDS IN THE P53 AMINO-TERMINAL DOMAIN ARE REQUIRED FOR TRANSCRIPTIONAL ACTIVATION, BINDING TO MDM-2 AND THE ADENOVIRUS-5 E1B 55-KD PROTEIN, GENES & DEVELOPMENT 8: 1235 (1994). · DOI
  27. 10.1016/0092-8674(92)90243-6 · DOI
  28. LOWE, S.W., STABILIZATION OF THE P53 TUMOR SUPPRESSOR IS INDUCED BY ADENOVIRUS-5 E1A AND ACCOMPANIES APOPTOSIS, GENES & DEVELOPMENT 7: 535 (1993). · DOI · Paper page
  29. MILNER, J, COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION, CELL 65: 765 (1991). · DOI · Paper page
  30. OBEROSLER, P, P53-CATALYZED ANNEALING OF COMPLEMENTARY SINGLE-STRANDED NUCLEIC-ACIDS, EMBO JOURNAL 12: 2389 (1993). · DOI
  31. PARK, D.J., TRANSACTIVATIONAL AND DNA-BINDING ABILITIES OF ENDOGENOUS P53 IN P53 MUTANT-CELL LINES, ONCOGENE 9: 1899 (1994).
  32. PAVLETICH, N.P., THE DNA-BINDING DOMAIN OF P53 CONTAINS THE 4 CONSERVED REGIONS AND THE MAJOR MUTATION HOT-SPOTS, GENES & DEVELOPMENT 7: 2556 (1993). · DOI
  33. PIETENPOL, J.A., SEQUENCE-SPECIFIC TRANSCRIPTIONAL ACTIVATION IS ESSENTIAL FOR GROWTH SUPPRESSION BY P53, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91: 1998 (1994).
  34. 10.1126/science.2144364 · DOI
  35. SACK, J. S., JOURNAL OF MOLECULAR GRAPHICS 6: 224 (1988).
  36. SHAULIAN, E, IDENTIFICATION OF A MINIMAL TRANSFORMING DOMAIN OF P53 - NEGATIVE DOMINANCE THROUGH ABROGATION OF SEQUENCE-SPECIFIC DNA-BINDING, MOLECULAR AND CELLULAR BIOLOGY 12: 5581 (1992).
  37. SOUSSI, T, STRUCTURAL ASPECTS OF THE P53 PROTEIN IN RELATION TO GENE EVOLUTION, ONCOGENE 5: 945 (1990).
  38. STURZBECHER, H.W., A C-TERMINAL ALPHA-HELIX PLUS BASIC REGION MOTIF IS THE MAJOR STRUCTURAL DETERMINANT OF P53 TETRAMERIZATION, ONCOGENE 7: 1513 (1992).
  39. UNGER, T, P53 - A TRANSDOMINANT REGULATOR OF TRANSCRIPTION WHOSE FUNCTION IS ABLATED BY MUTATIONS OCCURRING IN HUMAN CANCER, EMBO JOURNAL 11: 1383 (1992). · DOI
  40. VOGELSTEIN, B, P53 FUNCTION AND DYSFUNCTION, CELL 70: 523 (1992). · DOI
  41. WU, L, ALTERNATIVELY SPLICED FORMS IN THE CARBOXY-TERMINAL DOMAIN OF THE P53 PROTEIN REGULATE ITS ABILITY TO PROMOTE ANNEALING OF COMPLEMENTARY SINGLE STRANDS OF NUCLEIC-ACIDS, MOLECULAR AND CELLULAR BIOLOGY 15: 497 (1995). · DOI
  42. WU, X.W., P53 AND E2F-1 COOPERATE TO MEDIATE APOPTOSIS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91: 3602 (1994).
  43. YIN, Y.X., WILD-TYPE P53 RESTORES CELL-CYCLE CONTROL AND INHIBITS GENE AMPLIFICATION IN CELLS WITH MUTANT P53 ALLELES, CELL 70: 937 (1992). · DOI
  44. ZHANG, KYJ, SQUASH - COMBINING CONSTRAINTS FOR MACROMOLECULAR PHASE REFINEMENT AND EXTENSION, ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY 49: 213 (1993).

Cited by

See all 549

Metadata

Authors
Jeffrey, P. D., Gorina, S., & Pavletich, N. P.
Venue
Science
Publisher
American Association for the Advancement of Science (AAAS)
Published
1995-03-10
Volume
267
Issue
5203
Pages
1498-1502
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
DOI
10.1126/science.7878469
OpenAlex
W1996899753
Cited by
549
References
5
FWCI
10.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Crystal Structure of the Tetramerization Domain of the p53 Tumor Suppressor at 1.7 Angstroms. https://app.cochat.ai/papers/10.1126/science.7878469
The paper
Jeffrey, P. D., Gorina, S., & Pavletich, N. P. (1995). Crystal Structure of the Tetramerization Domain of the p53 Tumor Suppressor at 1.7 Angstroms. Science. https://doi.org/10.1126/science.7878469

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.